Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(18 sites)
United States
City of Hope, Duarte, California Colorado Blood Cancer Institute/SCRI, Denver, Colorado Karmanos Cancer Institute, Detroit, Michigan Roswell Park Comprehensive Cancer Center, Buffalo, New York Ohio State University, Columbus, Ohio